Search Results - "Fromigué, O."

Refine Results
  1. 1
  2. 2

    Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts by Le Mée, S., Fromigué, O., Marie, P.J.

    Published in Experimental cell research (2005)
    “…To determine the molecular mechanisms by which N-cadherin transcription is regulated, we cloned and sequenced a 3681-bp of the 5′-flanking region of the human…”
    Get full text
    Journal Article
  3. 3

    Bone Morphogenetic Protein-2 Promotes Osteoblast Apoptosis through a Smad-independent, Protein Kinase C-dependent Signaling Pathway by Hay, E, Lemonnier, J, Fromigue, O, Marie, P J

    Published in The Journal of biological chemistry (03-08-2001)
    “…Bone morphogenetic protein-2 (BMP-2), a member of the transforming growth factor-β (TGF-β) family, regulates osteoblast differentiation and bone formation…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Bone morphogenetic protein-2 and transforming growth factor-β2 interact to modulate human bone marrow stromal cell proliferation and differentiation by Fromigué, O., Marie, P.J., Lomri, A.

    Published in Journal of cellular biochemistry (15-03-1998)
    “…Osteoprogenitor cells in the human bone marrow stroma can be induced to differentiate into osteoblasts under stimulation with hormonal and local factors. We…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance by Habel, N, Hamidouche, Z, Girault, I, Patiño-García, A, Lecanda, F, Marie, P J, Fromigué, O

    Published in Cell death & disease (01-10-2013)
    “…Osteosarcoma is the most common primary tumor of bone occurring in children and adolescents. The histological response to chemotherapy represents a key…”
    Get full text
    Journal Article
  12. 12

    Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors by Habel, N, Vilalta, M, Bawa, O, Opolon, P, Blanco, J, Fromigué, O

    Published in Oncogene (11-06-2015)
    “…Osteosarcoma is the most prevalent primary pediatric cancer-related bone disease. These tumors frequently develop resistance to chemotherapy and are highly…”
    Get full text
    Journal Article
  13. 13

    Increased Osteoblast Apoptosis in Apert Craniosynostosis : Role of Protein Kinase C and Interleukin-1 by Lemonnier, Jerome, Hay, Eric, Delannoy, Philippe, Fromigue, Olivia, Lomri, Abderrahim, Modrowski, Dominique, Marie, Pierre J

    Published in The American journal of pathology (01-05-2001)
    “…Apert syndrome is an autosomal dominant disorder characterized by premature cranial ossification resulting from fibroblast growth factor receptor-2…”
    Get full text
    Journal Article
  14. 14

    RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42 p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation by Fromigué, O, Haÿ, E, Modrowski, D, Bouvet, S, Jacquel, A, Auberger, P, Marie, P J

    Published in Cell death and differentiation (01-11-2006)
    “…Osteosarcoma is the most common primary bone tumour in young adults. Despite improved prognosis, resistance to chemotherapy remains responsible for failure of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Active stromelysin‐3 (MMP‐11) increases MCF‐7 survival in three‐dimensional Matrigel culture via activation of p42/p44 MAP‐kinase by Fromigué, Olivia, Louis, Krystel, Wu, Erxi, Belhacène, Nathalie, Loubat, Agnès, Shipp, Margaret, Auberger, Patrick, Mari, Bernard

    Published in International journal of cancer (01-09-2003)
    “…Stromelysin‐3 (ST3) has the characteristic structure of matrix metalloproteinases (MMP), but its substrate specificity and pattern of expression differ…”
    Get full text
    Journal Article
  17. 17

    Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts by FROMIGUE, O, BODY, J. J

    Published in Journal of endocrinological investigation (01-06-2002)
    “…The key pharmacological action for the clinical use of bisphosphonates lies in the inhibition of osteoclast-mediated bone resorption. Osteoblasts could be…”
    Get full text
    Journal Article
  18. 18

    Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss by Ahdjoudj, S, Fromigué, O, Marie, P J

    Published in Histology and histopathology (01-01-2004)
    “…Human bone marrow stroma contains pluripotent mesenchymal progenitor cells that can give rise to many mesenchymal lineages, including chondroblasts, adipocytes…”
    Get full text
    Journal Article
  19. 19
  20. 20